Oric Pharmaceuticals, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Oric Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • Oric Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $261K, a 3.16% increase year-over-year.
  • Oric Pharmaceuticals, Inc. annual Depreciation for 2023 was $1.03M, a 6.83% increase from 2022.
  • Oric Pharmaceuticals, Inc. annual Depreciation for 2022 was $966K, a 7.69% increase from 2021.
  • Oric Pharmaceuticals, Inc. annual Depreciation for 2021 was $897K, a 7.53% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.03M +$66K +6.83% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 $966K +$69K +7.69% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 $897K -$73K -7.53% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $970K -$58K -5.64% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 $1.03M +$125K +13.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-21
2018 $903K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.